These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 2663504)

  • 21. Pharmacotherapy of gastrointestinal motor disorders.
    Schuurkes JA
    Rev Gastroenterol Mex; 1994; 59(2):165-70. PubMed ID: 7991970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pharmacological basis of the treatment of disorders of gastrointestinal motility].
    Vantrappen G; Hellemans J; Janssens J
    Acta Gastroenterol Belg; 1967 Oct; 30(10):646-58. PubMed ID: 5594398
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments.
    Hunt RH; Tougas G
    Best Pract Res Clin Gastroenterol; 2002 Dec; 16(6):869-83. PubMed ID: 12473296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological stimulation of gastrointestinal motility: where we are and where are we going?
    Scarpignato C
    Dig Dis; 1997; 15 Suppl 1():112-36. PubMed ID: 9177950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotility medications--now and in the future.
    Karamanolis G; Tack J
    Dig Dis; 2006; 24(3-4):297-307. PubMed ID: 16849857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythromycin and the gut.
    Catnach SM; Fairclough PD
    Gut; 1992 Mar; 33(3):397-401. PubMed ID: 1568663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacologic treatments of transit disorders].
    Manz M; Meier R
    Ther Umsch; 2007 Apr; 64(4):227-32. PubMed ID: 17663210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prokinetics in the Management of Functional Gastrointestinal Disorders.
    Quigley EMM
    Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motility disorders in the ICU: recent therapeutic options and clinical practice.
    Röhm KD; Boldt J; Piper SN
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The enteric nervous system II: gastrointestinal functions.
    Hansen MB
    Pharmacol Toxicol; 2003 Jun; 92(6):249-57. PubMed ID: 12787256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal motility disorders and gastrointestinal prokinetic therapy.
    Washabau RJ
    Vet Clin North Am Small Anim Pract; 2003 Sep; 33(5):1007-28, vi. PubMed ID: 14552159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prokinetic agents--their contribution to practice of gastroenterology].
    Hep A; Dolina J
    Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoids and the gastrointestinal tract.
    Pertwee RG
    Gut; 2001 Jun; 48(6):859-67. PubMed ID: 11358910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 36. Tachykinin receptors as drug targets for motility disorders.
    Hoogerwerf WA; Sarna SK
    Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine antagonists in the upper gastrointestinal tract.
    Valenzuela JE; Dooley CP
    Scand J Gastroenterol Suppl; 1984; 96():127-36. PubMed ID: 6382574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms.
    Di Lorenzo C; Lucanto C; Flores AF; Idries S; Hyman PE
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):508-12. PubMed ID: 9822313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are We Close to Targeting Enteric Glia in Gastrointestinal Diseases and Motility Disorders?
    Gulbransen BD; Christofi FL
    Gastroenterology; 2018 Aug; 155(2):245-251. PubMed ID: 29964042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.